Azurrx Biopharma Inc (AZRX) Earnings History & Surprises

NASDAQ:AZRX

3.45
+0.07 (+2.07%)
At close: Sep 21, 2021
3.42
-0.03 (-0.87%)
After Hours: 9/21/2021, 8:00:01 PM

Past quarterly earnings results for Azurrx Biopharma Inc (AZRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateN/A
PeriodQ3 / 2021
EPS Estimate-$0.08
Revenue Estimate

Last Reported

Most Recent
Release DateN/A
PeriodQ2 / 2021
EPS Reported-$0.16
EPS Surprise -116.36%
Revenue Surprise %

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History ()

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2021 -0.16 -0.07 -116.36% 5.88% - -
Q1 2021 -0.14 -0.07 -89.32% 30.00% - -
Q4 2020 -0.31 -0.14 -123.47% - - -
Q3 2020 -0.17 -0.14 -22.55% - - -
Q2 2020 -0.17 -0.11 -57.23% - - -
Q1 2020 -0.20 -0.12 -66.88% - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AZRX EPS Q2Q GrowthAZRX EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 20 40 60

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

Azurrx Biopharma Inc / AZRX Earnings FAQ

Did AZRX stock beat earnings estimates in the most recent quarter?

Azurrx Biopharma Inc (AZRX) missed EPS estimates and missed revenue estimates in the most recent quarter.